Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Zollinger-Ellison Syndrome × Dexlansoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Zollinger-Ellison Syndrome 1 Stomach Ulcer 1 Esophagitis, Peptic 1

Interventions

veliparib 1 cixutumumab 1 Temozolomide 1 Salts 1 Omeprazole 1 Octreotide 1 Lansoprazole 1 Everolimus 1 Esomeprazole 1 Dexlansoprazole 1 Clopidogrel 1 Capecitabine 1 Acetates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00942175 2012-02-03

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Takeda

Phase 1 Completed

160 enrolled 16 charts

Gastrointestinal

Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡